EichorEICHOR
Condition: Stage Iii Colon Cancer Ajcc V8 Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Stage Iii Colon Cancer Ajcc V8

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
Phase N/A · 3 location(s) · Mayo Clinic · NCT06349642Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · 1066 location(s) · NRG Oncology · NCT05174169Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
Phase 3 · 3 location(s) · Massachusetts General Hospital · NCT03803553Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or
Phase 2 · 5 location(s) · Emory University · NCT07140679MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon Cancer
NA · 1 location(s) · Sun Yat-sen University · NCT06204484Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
NA · 2 location(s) · Fred Hutchinson Cancer Center · NCT06995924Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
Phase N/A · 10 location(s) · M.D. Anderson Cancer Center · NCT04739072CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial)
Phase 2 · 9 location(s) · West China Hospital · NCT06242418Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03819296CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With
Phase 2 · 1 location(s) · Northwestern University · NCT05733000Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cance
NA · 13 location(s) · City of Hope Medical Center · NCT07125729Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Phase 1/Phase 2 · 23 location(s) · National Cancer Institute (NCI) · NCT05691491Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Pa
Phase 3 · 62 location(s) · ECOG-ACRIN Cancer Research Group · NCT05863195Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
Phase 2 · 11 location(s) · City of Hope Medical Center · NCT07595874Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survi
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06746012Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors
NA · 1 location(s) · Fred Hutchinson Cancer Center · NCT05930496Family Communications After Genetic Testing
NA · 299 location(s) · Alliance for Clinical Trials in Oncology · NCT07143487Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Can
Phase 3 · 187 location(s) · Alliance for Clinical Trials in Oncology · NCT05673148Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative I
Phase 2 · 4 location(s) · Emory University · NCT07405476Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER
Phase 2 · 1 location(s) · Baylor College of Medicine · NCT05870800Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer
Phase 2/Phase 3 · 1 location(s) · Chungnam National University Hospital · NCT05179889Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or G
Phase 1 · 1 location(s) · Roswell Park Cancer Institute · NCT04511039Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access an
Phase 2 · 1 location(s) · Mayo Clinic · NCT06265285French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT06287814Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Be
Phase 1 · 13 location(s) · National Cancer Institute (NCI) · NCT06696768Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cem
Phase 1/Phase 2 · 6 location(s) · National Cancer Institute (NCI) · NCT07147231
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.